Patient voice in clinical trial programs in industry

Abstract

Abstract In this Chapter, Patient Voice in Clinical Trial Programs in Industry, we argue that the Life Sciences industry must adapt if they are to succeed and make medicines with (rather than just for) patients. Those companies able to deliver medicines and interventions that reflect patient priorities and needs as identified through meaningful patient engagement will ultimately prosper. Regulatory bodies and initiatives established to promote patient engagement are providing incentives and platforms for multiple stakeholders to embed the patient perspective in product development. Collaborative approaches are providing practical guidance and frameworks for capturing patient insights. Increasingly, patients’ experiential knowledge is being incorporated into clinical research – including in real-world studies – facilitated by the availability of technology. Authentic patient engagement should strive to ensure representation of the whole population and care continuum. If the patient voice is to be respected in clinical trials programs, open, two-way communication and education will be essential.